Skip to content

INSM

Insmed Incorporated

Stock

$111.12+2.53 (+2.33%)Close Oct 2, 2026

Revenue, 2025
$606M
YoY, 2025
+66.7%
5-year CAGR
+29.8%

Revenue

Revenue by fiscal year

PeriodRevenueYoY
2025$606M+66.7%
2024$364M+19.2%
2023$305M+24.4%
2022$245M+30.2%
2021$188M+14.6%
2020$164M+20.5%
2019$136M+1,287.6%
2018$9.8M—
2017$0—
2016$0—
2015$0—
2013$12M—
2012$0−100.0%
2011$4.4M−36.2%
2010$6.9M−33.3%
2009$10M—